Filter
5495
Filtered Results: 5495
Text search:
drug
development
Featured
Recommendations
474
New Publications
1473
Language
Document type
No document type
3363
Studies & Reports
860
Guidelines
660
Manuals
228
Strategic & Response Plan
168
Fact sheets
78
Training Material
75
Situation Updates
20
Infographics
14
Resource Platforms
11
Brochures
8
Online Courses
7
Dashboards/Maps
1
App
1
Videos
1
Countries / Regions
India
313
Global
195
Kenya
175
South Africa
133
Ethiopia
130
Uganda
126
Nigeria
117
Western and Central Europe
110
Tanzania
103
Nepal
101
Sierra Leone
92
Liberia
89
Zambia
88
Malawi
85
Myanmar / Burma
80
Latin America and the Carribbean
74
Ghana
73
Africa
72
Bangladesh
71
Rwanda
65
Ukraine
57
Eastern Europe
57
Philippines
52
Namibia
52
Zimbabwe
44
Asia
41
South–East Asia Region
40
Cambodia
39
Russia
38
Lesotho
37
Indonesia
32
Botswana
29
Congo, Democratic Republic of
28
Mozambique
26
Syria
23
Eswatini/ Swaziland
23
Senegal
21
Burkina Faso
20
Colombia
19
Germany
19
Brazil
17
South Sudan
17
Cameroon
16
East and Southern Africa
16
USA
15
West and Central Africa
15
Haiti
14
Middle East and North Africa
14
Tajikistan
13
Albania
12
Venezuela
12
Pakistan
11
Thailand
10
China
10
Guinea
10
Afghanistan
9
Eastern Europe and Central Asia
9
Vietnam
9
Georgia
9
Argentina
8
Sudan
8
Armenia
7
Paraguay
7
Moldova
7
Mexico
6
Laos
6
Western Pacific Region
6
North America
6
Yemen
6
North Macedonia
5
Benin
5
Peru
5
Lebanon
5
Sri Lanka
5
Central African Republic
5
Iraq
5
El Salvador
4
Jordan
4
Jamaica
4
United Kingdom
4
Bhutan
4
Somalia
4
Madagascar
4
Timor Leste/ East Timor
3
Turkey
3
Iran
3
Fiji
3
Kyrgyzstan
3
Côte d’Ivoire / Ivory Coast
3
Bolivia
3
Papua New Guinea
3
Palestine
3
Mali
3
Angola
3
Libya
3
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Estonia
2
Uzbekistan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
France
2
Portugal
2
Spain
2
Belarus
2
Southern Africa
2
Poland
2
Honduras
2
Ecuador
2
North Korea
1
Switzerland
1
Australia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Chad
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2142
Clinical Guidelines
472
Public Health
268
Women & Child Health
214
Key Resources
155
Capacity Building
77
Pharmacy & Technologies
62
Annual Report MEDBOX
1
Toolboxes
HIV
621
Mental Health
549
TB
525
AMR
287
NTDs
240
COVID-19
207
Pharmacy
161
NCDs
117
Caregiver
108
Rapid Response
92
Ebola & Marburg
81
Planetary Health
78
Refugee
70
Disability
65
Global Health Education
61
Conflict
58
Health Financing Toolbox
53
Malaria
33
Polio
22
Natural Hazards
21
Specific Hazards
16
Cholera
16
Zika
16
Social Ethics
14
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry of Health, various agencies in the health sector, and other relevant stakeholders. It has been developed to provide strategic direction and support towa...
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions speci...
Based on the Vulnerability Index developed in this review, an estimated 22.7 million persons in Myanmar, or 44% of the population, were found to have some form of vulnerability related to human development and/or exposure to active conflict/violence. These people experience varying combinations of p...
Purpose of these Guidelines
These guidelines are designed to help members of the public to provide first aid to someone who is at risk of suicide. The role of the first aider is to assist the person until appropriate professional help is received or the crisis resolves.
Development of these Guidel...
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination...
The Rwandan Ministry of Health recognizes the threat that Non-Communicable Diseases (NCDs) pose to health and development in Rwanda and in 2009 articulates strategies to respond to them in the Health Sector Strategic Plan 2012 - 2018 (HSSP3). Among other things, the plan calls for a national prevale...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
Germany has become a visible actor in global health in the past 10 years. In this Series paper, we describe how this development complements a broad change in perspective in German foreign policy.
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
The focus of the current quarterly edition of Eurohealth (from the European Observatory on Health Systems and Policies) is Antimicrobial Resistance (AMR) and contains the following articles:
• Strengthening implementation of AMR national action plans
• Fostering clinical developmen...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three ...
Rwanda’s fourth health sector strategic plan (HSSP4) is meant to provide the health sector with a Strategic Plan that will highlight its commitments and priorities for the coming 6 years. It will be fully integrated in the overall economic development plan of the Government. HSSP4 will fulfill the...
